Beyond-Use Dating on Compounded Semaglutide: What the Date Really Tells You

Every compounded semaglutide vial has a date printed on the label. That date is not an expiration date — it's a beyond-use date, or BUD, and the distinction is not just semantic. Understanding what a BUD means (and what it doesn't) helps you make informed decisions about your medication's safety and potency.

Beyond-Use Date vs. Expiration Date

Brand-name drugs like Wegovy and Ozempic carry expiration dates set by the manufacturer based on years of stability testing under controlled conditions. These dates are reviewed and approved by the FDA as part of the drug's approval process. They represent a manufacturer's guarantee that the product will maintain its labeled potency and safety through the stated date when stored properly.

Beyond-use dates on compounded preparations work differently. They are set by the compounding pharmacy based on either the pharmacy's own stability testing data or default BUD criteria established by USP Chapter <797> (for sterile preparations) and Chapter <795> (for non-sterile preparations). BUDs are typically shorter than manufacturer expiration dates because compounded products lack the extensive long-term stability data that brand-name products undergo.

How BUDs Are Determined

USP <797> provides default BUDs for sterile compounded preparations based on the compounding conditions and testing performed. As of the current USP standards:

• Category 1 preparations (compounded under basic conditions, no sterility testing beyond process controls): BUDs of up to 12 hours at room temperature or up to 24 hours refrigerated.
• Category 2 preparations (compounded under more stringent conditions with additional quality controls): BUDs of up to 4 days at room temperature or up to 10 days refrigerated for non-preserved preparations. Preserved preparations (containing a bacteriostatic agent like benzyl alcohol) can have BUDs up to 30 days refrigerated.

These are default maximums. A pharmacy can assign a BUD longer than the USP defaults only if it has stability data from validated testing that supports the extended dating. This testing typically involves placing the compounded product under defined storage conditions and measuring potency, sterility, and degradation at timed intervals.

What "Stability Testing" Means in Practice

A pharmacy that claims a 90-day BUD for compounded semaglutide should have stability study data showing that the product retains its labeled potency, remains sterile, and does not develop unacceptable levels of degradation products through that entire period. This data should be:

• Specific to the exact formulation (concentration, preservative system, vehicle)
• Conducted under the labeled storage conditions (typically 2-8°C refrigerated)
• Tested at multiple time points (e.g., day 0, 30, 60, 90)
• Performed by a qualified laboratory, ideally independent of the pharmacy

Pharmacies that assign extended BUDs without supporting stability data are not following USP standards — and the potency of your medication at day 60 or 90 becomes an assumption rather than a verified fact.

Why BUDs Vary Between Pharmacies

If you've compared compounded semaglutide from different providers, you may have noticed different BUDs for seemingly similar products. This variation usually reflects differences in:

• Formulation: Different concentrations, preservative systems, or buffers can have different stability profiles.
• Testing investment: Pharmacies that invest in stability testing can justify longer BUDs. Those relying on USP defaults are limited to shorter dating.
• Compounding conditions: The physical infrastructure (cleanroom class, environmental monitoring) determines which USP category the preparation falls into, which sets the default BUD ceiling.

A longer BUD is not inherently better or worse — it depends on whether the dating is supported by data. A 30-day BUD from a pharmacy with testing data is more trustworthy than a 90-day BUD from one without it.

Practical Implications for Patients

Storage Matters

A BUD assumes you store the product as labeled. For most compounded semaglutide, this means refrigerated at 2-8°C (36-46°F). Leaving a vial at room temperature, in a hot car, or in direct sunlight can degrade the peptide faster than the BUD accounts for. The date on the label is only valid under the stated storage conditions.

Multi-Dose Vials After First Use

Once you puncture a multi-dose vial with a needle, the sterility clock resets regardless of the labeled BUD. USP <797> requires that multi-dose vials with bacteriostatic preservatives (like benzyl alcohol) be discarded within 28 days of first puncture — even if the labeled BUD extends further. Preservative-free multi-dose vials should be discarded within 24 hours of first puncture.

Don't Stockpile Past the Date

Using a compounded preparation beyond its BUD means you're using a product whose potency and sterility are no longer verified. The medication may still contain active semaglutide, but the concentration could have degraded, and sterility cannot be guaranteed. This is not a "sell by" date where a few days past doesn't matter — it's a clinical safety boundary.

Providers That Source From Quality-Focused Pharmacies

The Takeaway

The beyond-use date on your compounded semaglutide is a quality statement. It says: "This pharmacy can demonstrate that this product retains its labeled characteristics through this date, under these storage conditions." Pharmacies that invest in stability testing earn the right to extend that window. Those that don't are bound by USP defaults — which is conservative, but conservative is not a bad thing when it comes to injectable medications.